Why is the Silex (ASX:SLX) share price sliding 8% today on positive news?

The Silex (ASX: SLX) share price has dropped more than 8% today despite the company gaining the green light for its GLE restructure.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Silex Systems Ltd (ASX: SLX) share price is sliding lower today on news the United States government has approved the restructure of GE-Hitachi Global Laser Enrichment (GLE).

At the time of writing, the nuclear energy technology developer's shares are down 8.75% to $1.46.

The Silex share price has fallen today, despite the positive announcement. Could the share sell-down be due to investors already factoring in the outcome, which was first revealed on 8 January?

Downward red arrow with business man sliding down it signifying falling asx share price.

Image source: Getty Images

What's driving the Silex share price today?

In today's release, Silex advised it has formally received notice from the US Treasury Department Committee on Foreign Investment in the United States (CFIUS) to approve the transaction to restructure GLE.

The notice stated the CFIUS investigation found no national security concerns with the restructure. The latest approval now means that Silex has the go-ahead to proceed with its investment of GLE.

Silex will acquire a 51% stake, with uranium and nuclear fuel supplier Cameco to increase its interest from 24% to 49%.

As the deal draws close to being finalised, Silex, Cameco and GE-Hitachi Nuclear Energy (GEH) will shut down the membership interest purchase agreement (MIPA). Executed in December 2019, the joint agreement originally saw the purchase of GEH's 76% interest in GLE.

It is expected that the closure of MIPA will be concluded in the next few weeks.

Words from the CEO

Silex CEO and managing director Dr Michael Goldsworthy welcomed the news, saying:

The receipt of approval from CFIUS for the GLE transaction represents a significant milestone for Silex and reflects the dedicated efforts by the Silex team, our colleagues at Cameco and GEH, along with many representatives within the US Government, and we thank everyone for their contribution.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Two men celebrate while another holds his head in his hands, after watching the race.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a strange day on the ASX.

Read more »

Rocket going up above mountains, symbolising a record high.
Broker Notes

2 ASX mining shares tipped by experts to rocket 55% to 85%

One is a copper miner, the other is an iron ore producer.

Read more »

Happy miner with his hand in the air.
Resources Shares

BHP shares just hit a new all-time high. Here's why

The Big Australian has a big new share price to match it.

Read more »

A happy person clenching fists in celebration sitting at computer.
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »

graphic image of a crown dropping on its side and shattering
Share Market News

BHP shares regain their market crown as CBA slides 10%

The 'Big Australian' is once again at the top of the ASX 200.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Broker Notes

3 ASX 200 shares predicted to double over 12 months

These stocks are on a different trajectory to the ASX 200, which has slipped into the red for 2026.

Read more »

Six smiling health workers pose for a selfie.
Broker Notes

3 reasons this beaten down ASX All Ords healthcare share could come roaring back

A leading analyst believes this beaten down ASX healthcare stock is well-positioned for a comeback.

Read more »

A couple sits on a sofa, each clutching their heads in horror and disbelief, while looking at a laptop screen.
Healthcare Shares

Down 59%: Will CSL shares ever regain momentum?

Here's what to expect over the next 12 months.

Read more »